Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Ipilimumab × 1 year × Clear all

Sponsor

Conditions

Melanoma 65 Carcinoma, Renal Cell 33 Carcinoma, Non-Small-Cell Lung 33 Neoplasm Metastasis 22 Colorectal Neoplasms 13 Carcinoma, Hepatocellular 13 Brain Neoplasms 13 Skin Neoplasms 11 Neoplasms 11 Uveal Melanoma 10 Squamous Cell Carcinoma of Head and Neck 10 Lung Neoplasms 10 Ovarian Neoplasms 9 Kidney Neoplasms 9 Urinary Bladder Neoplasms 8 Sarcoma 8 Prostatic Neoplasms 8 Carcinoma, Transitional Cell 7 Small Cell Lung Carcinoma 6 Pancreatic Neoplasms 6 Glioblastoma 6 Colonic Neoplasms 6 Carcinoma, Merkel Cell 6 Recurrence 5 Multiple Myeloma 5 Mesothelioma, Malignant 5 Mesothelioma 5 Carcinoma, Neuroendocrine 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡